Cefodizime
- Level
- Commodity
- Parent
- 51284100
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51284122This classification denotes a beta-lactam antibacterial with the molecular formula C20H20N6O7S4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HC1T51593A, chemically known as (6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(((5-(carboxymethyl)-4-methyl-2-thiazolyl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(z)-(o-methyloxime) but generally known as cefodizime, which bears US NIH Compound Identifier 5361871. Most nations schedule cefodizime under HS 29419000 and SITC 54139. As of Q4 2014, CEFODIZIME remains the US FDA Preferred Term for this commodity. Cefodizime bears US NLM identifiers UMLS ID C0055007 and NCI Concept Code C98224. SMILES: CC1=C(SC(=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O)CC(=O)O.
Same parent
Under 51284100 · 50Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.